Skip to content
Electromed logo

Electromed

ELMD

Electromed is a medical - devices company in the healthcare sector trading on AMEX, led by CEO James L. Cunniff, with a market cap of $379.4M.

Market cap
$379.39M+126%
Revenue$71.8M+16.8%
Net income$10.1M+41.1%
Free cash flow$9.4M-21.3%
Trailing twelve months · change vs. prior year

Earnings

Next report

Aug 25, 2026 (in a month)
Revenue estimate$19.3M
EPS estimate$0.32

Financials

Q3 2026

Income statement

See full
Revenue$18.6M+18.4%
Net income$3.0M+58.8%

Cash flow

See full
Operating cash flow$3.5M+67.6%
CapEx$147.0K
Free cash flow$3.3M+49.5%

Valuation & ratios

Valuation

See full
Market cap$379.39M+126%
P/E37.6×+15.2×
P/S5.3×+2.7×

Profitability

See full
Net margin14.1%+2.4pp
FCF margin13%-6.3pp

Profile

Listed2010
Employees170.0
CEOJames L. Cunniff
FilingsSEC EDGAR

Questions, answered.

What is Electromed's market cap?
Electromed (ELMD) has a market capitalization of $379.4M and trades on AMEX.
What is Electromed's revenue and profitability?
Electromed generated $71.8M in trailing twelve-month revenue with net income of $10.1M, representing a net margin of 14.1%. Gross margin stands at 76.8%, with free cash flow of $9.4M. These figures are based on the Q1 2026 filing.
Where is Electromed headquartered?
Electromed is headquartered in United States of America and employs approximately 170 people. It has been publicly traded since 2010.